复发性流产蜕膜衰老中FOXM1靶向孕激素治疗研究
该体外研究比较了复发性流产(RPL)与健康妊娠妇女原代蜕膜细胞,发现RPL组FOXM1表达降低、衰老标志物升高;醋酸甲羟孕酮(MPA)和地屈孕酮(DYD)可改善蜕膜功能并恢复FOXM1表达,但未逆转衰老标志物,提示联合衰老调节剂可能是有前景的研究方向。
要点
- RPL蜕膜细胞FOXM1表达降低且衰老标志物升高。
- MPA和DYD改善RPL蜕膜功能并恢复FOXM1表达。
- 两药未显著降低DIO2或β-GAL衰老标志物表达。
核心结论
- RPL妇女蜕膜细胞FOXM1表达降低且衰老相关标志物增加。
- MPA和DYD可恢复FOXM1表达并改善蜕膜功能,但未逆转衰老标志物表达。
- 联合衰老调节剂与孕激素类似物可能是未来机制和转化研究的有前景方向。
研究设计与样本
- 体外研究,从健康妊娠自愿终止者(对照组,n=10)和RPL妇女(RPL组,n=10)的蜕膜组织分离原代蜕膜细胞。
- 细胞经MPA和DYD处理,ELISA分析PRL和IGFBP-1浓度,免疫荧光检测FOXO1、FOXM1、p-FOXM1、DIO2和β-GAL表达。
- 与AC-1M88滋养细胞样细胞共培养评估球体扩展和迁移。
主要发现
- MPA和DYD显著改善RPL组PRL浓度(分别P=0.006和P=0.015)和IGFBP-1浓度(均P<0.001)。
- MPA和DYD显著改善RPL组FOXO1、FOXM1和p-FOXM1表达(均P<0.001)。
- DYD在恢复FOXM1和p-FOXM1表达上比MPA更有效(均P<0.001)。
- MPA和DYD未影响RPL组球体扩展,但增加细胞迁移(分别p=0.009和p<0.001)。
- MPA和DYD均未显著降低DIO2或β-GAL表达。
临床怎么用
- 孕激素类似物MPA和DYD可改善RPL蜕膜功能,但单用不能逆转蜕膜衰老标志物。
- 未来可探索衰老调节剂联合孕激素类似物用于RPL的机制和转化研究。
局限性
- 研究为体外原代蜕膜细胞模型,样本量每组10例,结论需临床研究验证。
- 未观察到MPA和DYD对DIO2或β-GAL衰老标志物的显著降低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: What is the role of FOXM1 in the pathogenesis of recurrent pregnancy loss (RPL) characterized by increased decidual senescence, and how do two progesterone analogues (medroxyprogesterone acetate [MPA] and dydrogesterone [DYD]) modulate FOXM1 expression and associated senescence markers in an in-vitro decidualization model? DESIGN: Primary decidual cells were isolated from decidual tissue samples collected from women with clinically healthy pregnancies that were terminated voluntarily (control pregnancy group, n = 10) and women with RPL (RPL group, n = 10). Cells were treated with MPA and DYD, and PRL and IGFBP-1 concentrations were analysed by ELISA. FOXO1, FOXM1, phospho-FOXM1 (p-FOXM1), DIO2 and β-GAL expression was examined by immunofluorescence. Co-culture experiments with AC-1M88 trophoblast-like cells assessed spheroid expansion and migration. RESULTS: MPA and DYD treatments significantly ameliorated PRL (P = 0.006 and P = 0.015, respectively) and IGFBP-1 (both P < 0.001) concentrations, and FOXO1, FOXM1 and p-FOXM1 expression (all P < 0.001), in the RPL group. DYD treatment was more effective than MPA treatment in restoring FOXM1 and p-FOXM1 expression (both P < 0.001). MPA and DYD did not affect spheroid expansion in the RPL group but increased cell migration (p=0.009 and p<0.001, respectively); however, neither treatment significantly reduced DIO2 or β-GAL expression. CONCLUSIONS: Decidual cells from women with RPL exhibited reduced FOXM1 expression and increased senescence-associated markers. MPA and DYD restored FOXM1 expression and improved decidual function, but did not reverse senescence marker expression. These findings suggest that combining senomorphic agents with progesterone analogues may represent a promising avenue for future mechanistic and translational research.
引用
- Kendirci-Katirci R, Katirci E, Sanhal CY, et al. Decidual senescence in recurrent pregnancy loss: forkhead box M1-targeted progesterone treatment. Reprod Biomed Online. 2026. PMID: 42143847. doi:10.1016/j.rbmo.2026.105663
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。